ANSUVIMAB
Dead / Abandoned — Abandoned — no statement of use filed (as of 21 Jun 2021)
What this means for you
This application is over — abandoned 21 Jun 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88921860
- Mark type
- Stylized text
- Filed
- 18 May 2020
- Published for opposition
- 22 Sept 2020
- Abandoned
- 21 Jun 2021
- Attorney of record
- Michael J. Zinna
Goods and services
- Class 005 — Pharmaceuticals: Human antibody-based pharmaceutical for treatment and prophylaxis for Ebola Virus Disease
- Class 044 — Medical, beauty and agricultural services: Treatment and prophylaxis for Ebola Virus Disease using human antibodies
Owner
- RIDGEBACK BIOTHERAPEUTICS L.P., Coconut Grove, FL, US
- RIDGEBACK BIOTHERAPEUTICS L.P., Coconut Grove, FL, US
Prosecution history
- 21 Jun 2021 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 21 Jun 2021 — ABANDONMENT - NO USE STATEMENT FILED
- 17 Nov 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 22 Sept 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Sept 2020 — PUBLISHED FOR OPPOSITION
- 02 Sept 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Aug 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 15 Aug 2020 — ASSIGNED TO EXAMINER
- 04 Jun 2020 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 21 May 2020 — NEW APPLICATION ENTERED